Healthcare Trust of America, Inc. (NYSE:HTA) has received an average recommendation of “Buy” from the thirteen brokerages that are covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating, seven have given a buy rating and two have issued a strong buy rating on the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $34.50.

HTA has been the topic of several recent analyst reports. Jefferies Group LLC upgraded Healthcare Trust of America to a “buy” rating and set a $36.00 target price on the stock in a report on Monday, June 5th. Zacks Investment Research upgraded Healthcare Trust of America from a “sell” rating to a “hold” rating in a report on Wednesday, June 7th. Wells Fargo & Company reiterated an “outperform” rating and set a $35.00 target price (up from $33.50) on shares of Healthcare Trust of America in a report on Friday, June 16th. BMO Capital Markets upgraded Healthcare Trust of America from a “market perform” rating to an “outperform” rating and lifted their target price for the stock from $33.00 to $35.00 in a report on Tuesday, June 20th. They noted that the move was a valuation call. Finally, Mizuho reiterated a “buy” rating on shares of Healthcare Trust of America in a report on Tuesday, June 27th.

In other news, CEO Scott D. Peters sold 55,240 shares of the business’s stock in a transaction dated Tuesday, June 27th. The stock was sold at an average price of $32.06, for a total value of $1,770,994.40. Following the sale, the chief executive officer now directly owns 405,092 shares in the company, valued at $12,987,249.52. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Insiders own 1.50% of the company’s stock.

Large investors have recently added to or reduced their stakes in the stock. Westpac Banking Corp acquired a new stake in shares of Healthcare Trust of America in the second quarter valued at about $7,499,000. Legal & General Group Plc increased its position in shares of Healthcare Trust of America by 39.9% in the second quarter. Legal & General Group Plc now owns 532,683 shares of the real estate investment trust’s stock valued at $16,572,000 after acquiring an additional 151,890 shares during the last quarter. US Bancorp DE increased its position in shares of Healthcare Trust of America by 1,142.9% in the second quarter. US Bancorp DE now owns 4,350 shares of the real estate investment trust’s stock valued at $135,000 after acquiring an additional 4,000 shares during the last quarter. Schwab Charles Investment Management Inc. increased its position in shares of Healthcare Trust of America by 15.1% in the first quarter. Schwab Charles Investment Management Inc. now owns 678,084 shares of the real estate investment trust’s stock valued at $21,333,000 after acquiring an additional 88,903 shares during the last quarter. Finally, Morgan Stanley increased its position in shares of Healthcare Trust of America by 49.4% in the first quarter. Morgan Stanley now owns 365,861 shares of the real estate investment trust’s stock valued at $11,510,000 after acquiring an additional 120,948 shares during the last quarter. 97.75% of the stock is currently owned by institutional investors and hedge funds.

TRADEMARK VIOLATION NOTICE: “Healthcare Trust of America, Inc. (HTA) Receives Average Recommendation of “Buy” from Analysts” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this news story on another site, it was copied illegally and reposted in violation of US & international copyright law. The original version of this news story can be accessed at https://www.thecerbatgem.com/2017/09/22/healthcare-trust-of-america-inc-hta-receives-average-recommendation-of-buy-from-analysts.html.

Healthcare Trust of America (NYSE HTA) traded down 1.045% on Friday, reaching $29.835. The company had a trading volume of 633,533 shares. Healthcare Trust of America has a 12 month low of $26.34 and a 12 month high of $34.35. The firm has a 50 day moving average price of $30.54 and a 200-day moving average price of $31.00. The stock has a market capitalization of $5.99 billion, a price-to-earnings ratio of 146.250 and a beta of 0.32.

Healthcare Trust of America (NYSE:HTA) last posted its earnings results on Monday, July 31st. The real estate investment trust reported $0.39 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.39. The firm had revenue of $139.90 million for the quarter, compared to analyst estimates of $133.69 million. Healthcare Trust of America had a return on equity of 1.42% and a net margin of 6.07%. The company’s revenue for the quarter was up 23.6% on a year-over-year basis. During the same period in the previous year, the company posted $0.38 earnings per share. Analysts forecast that Healthcare Trust of America will post $0.26 earnings per share for the current fiscal year.

The company also recently declared a quarterly dividend, which will be paid on Friday, October 6th. Stockholders of record on Monday, October 2nd will be issued a $0.305 dividend. This represents a $1.22 dividend on an annualized basis and a dividend yield of 4.08%. This is a positive change from Healthcare Trust of America’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend is Friday, September 29th. Healthcare Trust of America’s payout ratio is 571.43%.

Healthcare Trust of America Company Profile

Healthcare Trust of America, Inc is a real estate investment trust. The Company is an owner and operator of medical office buildings (MOBs) in the United States. The Company focuses on owning and operating MOBs that serve healthcare delivery and are located on health system campuses, near university medical centers, or in community core outpatient locations.

Analyst Recommendations for Healthcare Trust of America (NYSE:HTA)

Receive News & Stock Ratings for Healthcare Trust of America Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Trust of America Inc. and related stocks with our FREE daily email newsletter.